Cargando…
Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study
BACKGROUND: Youper is a widely used, commercially available mobile app that uses artificial intelligence therapy for the treatment of anxiety and depression. OBJECTIVE: Our study examined the acceptability and effectiveness of Youper. Further, we tested the cumulative regulation hypothesis, which po...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423345/ https://www.ncbi.nlm.nih.gov/pubmed/34155984 http://dx.doi.org/10.2196/26771 |
_version_ | 1783749449510551552 |
---|---|
author | Mehta, Ashish Niles, Andrea Nicole Vargas, Jose Hamilton Marafon, Thiago Couto, Diego Dotta Gross, James Jonathan |
author_facet | Mehta, Ashish Niles, Andrea Nicole Vargas, Jose Hamilton Marafon, Thiago Couto, Diego Dotta Gross, James Jonathan |
author_sort | Mehta, Ashish |
collection | PubMed |
description | BACKGROUND: Youper is a widely used, commercially available mobile app that uses artificial intelligence therapy for the treatment of anxiety and depression. OBJECTIVE: Our study examined the acceptability and effectiveness of Youper. Further, we tested the cumulative regulation hypothesis, which posits that cumulative emotion regulation successes with repeated intervention engagement will predict longer-term anxiety and depression symptom reduction. METHODS: We examined data from paying Youper users (N=4517) who allowed their data to be used for research. To characterize the acceptability of Youper, we asked users to rate the app on a 5-star scale and measured retention statistics for users’ first 4 weeks of subscription. To examine effectiveness, we examined longitudinal measures of anxiety and depression symptoms. To test the cumulative regulation hypothesis, we used the proportion of successful emotion regulation attempts to predict symptom reduction. RESULTS: Youper users rated the app highly (mean 4.36 stars, SD 0.84), and 42.66% (1927/4517) of users were retained by week 4. Symptoms decreased in the first 2 weeks of app use (anxiety: d=0.57; depression: d=0.46). Anxiety improvements were maintained in the subsequent 2 weeks, but depression symptoms increased slightly with a very small effect size (d=0.05). A higher proportion of successful emotion regulation attempts significantly predicted greater anxiety and depression symptom reduction. CONCLUSIONS: Youper is a low-cost, completely self-guided treatment that is accessible to users who may not otherwise access mental health care. Our findings demonstrate the acceptability and effectiveness of Youper as a treatment for anxiety and depression symptoms and support continued study of Youper in a randomized clinical trial. |
format | Online Article Text |
id | pubmed-8423345 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-84233452021-10-18 Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study Mehta, Ashish Niles, Andrea Nicole Vargas, Jose Hamilton Marafon, Thiago Couto, Diego Dotta Gross, James Jonathan J Med Internet Res Original Paper BACKGROUND: Youper is a widely used, commercially available mobile app that uses artificial intelligence therapy for the treatment of anxiety and depression. OBJECTIVE: Our study examined the acceptability and effectiveness of Youper. Further, we tested the cumulative regulation hypothesis, which posits that cumulative emotion regulation successes with repeated intervention engagement will predict longer-term anxiety and depression symptom reduction. METHODS: We examined data from paying Youper users (N=4517) who allowed their data to be used for research. To characterize the acceptability of Youper, we asked users to rate the app on a 5-star scale and measured retention statistics for users’ first 4 weeks of subscription. To examine effectiveness, we examined longitudinal measures of anxiety and depression symptoms. To test the cumulative regulation hypothesis, we used the proportion of successful emotion regulation attempts to predict symptom reduction. RESULTS: Youper users rated the app highly (mean 4.36 stars, SD 0.84), and 42.66% (1927/4517) of users were retained by week 4. Symptoms decreased in the first 2 weeks of app use (anxiety: d=0.57; depression: d=0.46). Anxiety improvements were maintained in the subsequent 2 weeks, but depression symptoms increased slightly with a very small effect size (d=0.05). A higher proportion of successful emotion regulation attempts significantly predicted greater anxiety and depression symptom reduction. CONCLUSIONS: Youper is a low-cost, completely self-guided treatment that is accessible to users who may not otherwise access mental health care. Our findings demonstrate the acceptability and effectiveness of Youper as a treatment for anxiety and depression symptoms and support continued study of Youper in a randomized clinical trial. JMIR Publications 2021-06-22 /pmc/articles/PMC8423345/ /pubmed/34155984 http://dx.doi.org/10.2196/26771 Text en ©Ashish Mehta, Andrea Nicole Niles, Jose Hamilton Vargas, Thiago Marafon, Diego Dotta Couto, James Jonathan Gross. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 22.06.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Mehta, Ashish Niles, Andrea Nicole Vargas, Jose Hamilton Marafon, Thiago Couto, Diego Dotta Gross, James Jonathan Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study |
title | Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study |
title_full | Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study |
title_fullStr | Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study |
title_full_unstemmed | Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study |
title_short | Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study |
title_sort | acceptability and effectiveness of artificial intelligence therapy for anxiety and depression (youper): longitudinal observational study |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423345/ https://www.ncbi.nlm.nih.gov/pubmed/34155984 http://dx.doi.org/10.2196/26771 |
work_keys_str_mv | AT mehtaashish acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy AT nilesandreanicole acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy AT vargasjosehamilton acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy AT marafonthiago acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy AT coutodiegodotta acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy AT grossjamesjonathan acceptabilityandeffectivenessofartificialintelligencetherapyforanxietyanddepressionyouperlongitudinalobservationalstudy |